secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2023-10-12T23:59:59+00:00
Accession:  0001437749-23-028151
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve equity plan boost: 10M more shares plus evergreen provision
--------------------------------------------------------------------------------

- Approved Second Amended and Restated 2020 Equity Incentive Plan increasing authorized shares by 10M to 56M total.
- Added evergreen provision: each quarter, pool resets to greater of 56M shares or 13% of outstanding shares.
- Plan term extended to ten years from October 6, 2023 annual meeting date.
- Elected Lori A. Woods, Heidi Henson, Frank Morich, Johan Spoor, and Robert Williamson as directors.
- Ratified Assure CPA as independent auditor for FY 2023; votes: 157M for, 2.3M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000143774923028151/0001437749-23-028151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000143774923028151/isr20231007_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-028151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer